Australia markets closed

Progyny, Inc. (PGNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
63.21+1.94 (+3.17%)
At close: 4:00PM EDT
63.21 0.00 (0.00%)
After hours: 05:17PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 55.09B
Enterprise value 35.00B
Trailing P/E 73.10
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)12.60
Price/book (mrq)24.89
Enterprise value/revenue 311.12
Enterprise value/EBITDA 7160.95

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3136.83%
S&P500 52-week change 333.64%
52-week high 366.61
52-week low 323.56
50-day moving average 358.93
200-day moving average 356.22

Share statistics

Avg vol (3-month) 3891.12k
Avg vol (10-day) 3515.64k
Shares outstanding 589.39M
Implied shares outstanding 6N/A
Float 868.84M
% held by insiders 15.29%
% held by institutions 187.44%
Shares short (29 Sept 2021) 45.05M
Short ratio (29 Sept 2021) 44.47
Short % of float (29 Sept 2021) 49.44%
Short % of shares outstanding (29 Sept 2021) 45.65%
Shares short (prior month 30 Aug 2021) 44.22M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021


Profit margin 17.28%
Operating margin (ttm)8.61%

Management effectiveness

Return on assets (ttm)9.90%
Return on equity (ttm)48.00%

Income statement

Revenue (ttm)450.01M
Revenue per share (ttm)5.16
Quarterly revenue growth (yoy)99.10%
Gross profit (ttm)70.06M
Net income avi to common (ttm)77.79M
Diluted EPS (ttm)0.78
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)93.97M
Total cash per share (mrq)1.05
Total debt (mrq)9.1M
Total debt/equity (mrq)4.45
Current ratio (mrq)2.41
Book value per share (mrq)2.29

Cash flow statement

Operating cash flow (ttm)14.93M
Levered free cash flow (ttm)7.3M